- Previous Close
0.0160 - Open
0.0160 - Bid 0.0160 x --
- Ask 0.0180 x --
- Day's Range
0.0160 - 0.0170 - 52 Week Range
0.0160 - 0.0440 - Volume
570,997 - Avg. Volume
240,725 - Market Cap (intraday)
10.227M - Beta (5Y Monthly) 0.89
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date Feb 28, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. The company offers rapid diagnostic test devices for HIV screening, pregnancy test, and respiratory test. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.
atomodiagnostics.comRecent News: AT1.AX
View MorePerformance Overview: AT1.AX
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AT1.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AT1.AX
View MoreValuation Measures
Market Cap
10.23M
Enterprise Value
7.53M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.52
Price/Book (mrq)
1.38
Enterprise Value/Revenue
1.86
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-153.10%
Return on Assets (ttm)
-31.72%
Return on Equity (ttm)
-61.15%
Revenue (ttm)
4.22M
Net Income Avi to Common (ttm)
-6.45M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
2.9M
Total Debt/Equity (mrq)
2.69%
Levered Free Cash Flow (ttm)
-1.59M